Task Force IV: Cardiovascular Effects of Emerging Infectious Diseases and Biological Terrorism Threats. Basic, Clinical, and Population Science Research and Training Needs

Journal of the American College of Cardiology

Volumn 49, Issue 12, 2007, Pages 1407-1412

  Madjid, Mohammad ^a   Luepker, Russell V ^a   Greenlund, Kurt J ^a   Taubert, Kathryn A ^a   Roy, Michael J ^a   Robertson, Rose Marie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ACUTE CORONARY SYNDROME; ANTHRAX; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL WARFARE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; DISASTER; DISEASE COURSE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; INFLUENZA; MORBIDITY; MORTALITY; NONHUMAN; PERICARDITIS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SURVIVAL; SYMPTOMATOLOGY;

ADVISORY COMMITTEES; BIOMEDICAL RESEARCH; BIOTERRORISM; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS; TRAINING SUPPORT;

EID: 33947527212     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.022     Document Type: Review

References (61)

1. Osler W. Lectures on angina pectoris and allied states (1897). In: Fye B.F. (Ed). William Osler's Collected Papers on the Cardiovascular System (1985), L.B. Adams, New York, NY 239-257
2. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
3. Madjid M., Naghavi M., Litovsky S., and Casscells S.W. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 108 (2003) 2730-2736
4. Casey C.G., Iskander J.K., Roper M.H., et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 294 (2005) 2734-2743
5. Leor J., Poole W.K., and Kloner R.A. Sudden cardiac death triggered by an earthquake. N Engl J Med 334 (1996) 413-419
6. Muller J.E., and Verrier R.L. Triggering of sudden death-lessons from an earthquake. N Engl J Med 334 (1996) 460-461
7. Meisel S.R., Kutz I., Dayan K.I., et al. Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 338 (1991) 660-661
8. Drazen J.M. Case clusters of the severe acute respiratory syndrome. N Engl J Med 348 (2003) e6-e7
9. Webby R.J., and Webster R.G. Are we ready for pandemic influenza?. Science 302 (2003) 1519-1522
10. Nash D., Mostashari F., Fine A., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344 (2001) 1807-1814
11. Mostashari F., Bunning M.L., Kitsutani P.T., et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358 (2001) 261-264
12. Thacker P.D. An Ebola epidemic simmers in Africa: in remote region, outbreak shows staying power. JAMA 290 (2003) 317-319
13. Lane H.C., Montagne J.L., and Fauci A.S. Bioterrorism: a clear and present danger. Nat Med 7 (2001) 1271-1273
14. Henderson D.A., Inglesby T.V., Bartlett J.G., et al., Working Group on Civilian Biodefense. Smallpox as a biological weapon: medical and public health management. JAMA 281 (1999) 2127-2137
15. Lim P.L., Kurup A., Gopalakrishna G., et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 350 (2004) 1740-1745
16. Accidental exposure to smallpox vaccine, Russian Federation. Wkly Epidemiol Rec 75 (2000) 202
17. Cardiac adverse events following smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 248-250
18. Halsell J.S., Riddle J.R., Atwood J.E., et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289 (2003) 3283-3289
19. Glezen W.P., Payne A.A., Snyder D.N., and Downs T.D. Mortality and influenza. J Infect Dis 146 (1982) 313-321
20. Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., and Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol 160 (2004) 492-502
21. Collins S. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Pub Health Rep 47 (1932) 2159-2179
22. Azambuja M.I., and Duncan B.B. Similarities in mortality patterns from influenza in the first half of the 20th century and the rise and fall of ischemic heart disease in the United States: a new hypothesis concerning the coronary heart disease epidemic. Cad Saude Publica 18 (2002) 557-577
23. Schlenger W.E., Caddell J.M., Ebert L., et al. Psychological reactions to terrorist attacks: findings from the National Study of Americans' Reactions to September 11. JAMA 288 (2002) 581-588
24. Qureshi E.A., Merla V., Steinberg J., and Rozanski A. Terrorism and the heart: implications for arrhythmogenesis and coronary artery disease. Card Electrophysiol Rev 7 (2003) 80-84
25. Lin L.Y., Wu C.C., Liu Y.B., Ho Y.L., Liau C.S., and Lee Y.T. Derangement of heart rate variability during a catastrophic earthquake: a possible mechanism for increased heart attacks. Pacing Clin Electrophysiol 24 (2001) 1596-1601
26. Peiris J.S., Chu C.M., Cheng V.C., et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361 (2003) 1767-1772
27. Update: cardiac and other adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 639-642
28. Ahlberg B., Linroth K., and Nordgren B. ECG changes without subjective symptoms after smallpox vaccination of military personnel. Acta Med Scand 464 (1966) 127-134
29. Arness M.K., Eckart R.E., Love S.S., et al. Myopericarditis following smallpox vaccination. Am J Epidemiol 160 (2004) 642-651
30. Rozanski A., Blumenthal J.A., and Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 (1999) 2192-2217
31. Ford D.E., Mead L.A., Chang P.P., Cooper-Patrick L., Wang N.Y., and Klag M.J. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 158 (1998) 1422-1426
32. Das S., and O'Keefe J.H. Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr Atheroscler Rep 8 (2006) 111-118
33. Bravata D.M., McDonald K.M., Smith W.M., et al. Systematic review: surveillance systems for early detection of bioterrorism-related diseases. Ann Intern Med 140 (2004) 910-922
34. Lombardo J., Burkom H., Elbert E., et al. A systems overview of the Electronic Surveillance System for the Early Notification of Community-Based Epidemics (ESSENCE II). J Urban Health 80 (2003) i32-i42
35. Townes J.M., Kohn M.A., Southwick K.L., et al. Investigation of an electronic emergency department information system as a data source for respiratory syndrome surveillance. J Public Health Manag Pract 10 (2004) 299-307
36. Lober W.B., Trigg L.J., Karras B.T., et al. Syndromic surveillance using automated collection of computerized discharge diagnoses. J Urban Health 80 (2003) i97-i106
37. Mostashari F., Fine A., Das D., Adams J., and Layton M. Use of ambulance dispatch data as an early warning system for communitywide influenzalike illness, New York City. J Urban Health 80 (2003) i43-i49
38. Mirhaji P., Zhang J., Smith J.W., Madjid M., Casscells S.W., and Lillibridge S.R. Informatics critical to public health surveillance. SPIE Proc 5071 (2003) 151-163
39. Heffernan R., Mostashari F., Das D., Karpati A., Kuldorff M., and Weiss D. Syndromic surveillance in public health practice, New York City. Emerg Infect Dis 10 (2004) 858-864
40. Syndromic surveillance for bioterrorism following the attacks on the World Trade Center-New York City, 2001. MMWR Morb Mortal Wkly Rep 51 (2002) 13-15
41. Goodwin T., and Noji E. Syndromic surveillance. Eur J Emerg Med 11 (2004) 1-2
42. Schwartz P.J., Zaza A., Locati E., and Moss A.J. Stress and sudden death. The case of the long QT syndrome. Circulation 83 (1991) II71-II80
43. Vaiva G., Ducrocq F., Jezequel K., et al. Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma. Biol Psychiatry 54 (2003) 947-949
44. Stohr K. The global agenda on influenza surveillance and control. Vaccine 21 (2003) 1744-1748
45. Hansson G.K. The B cell: a good guy in vascular disease?. Arterioscler Thromb Vasc Biol 22 (2002) 523-524
46. Inglesby T.V., Henderson D.A., O'Toole T., and Dennis D.T. Safety precautions to limit exposure from plague-infected patients. JAMA 284 (2000) 1648-1649
47. Inglesby T.V., O'Toole T., Henderson D.A., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287 (2002) 2236-2252
48. Inglesby T.V., Henderson D.A., Bartlett J.G., et al., Working Group on Civilian Biodefense. Anthrax as a biological weapon: medical and public health management. JAMA 281 (1999) 1735-1745
49. Arnon S.S., Schechter R., Inglesby T.V., et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285 (2001) 1059-1070
50. Dennis D.T., Inglesby T.V., Henderson D.A., et al. Tularemia as a biological weapon: medical and public health management. JAMA 285 (2001) 2763-2773
51. Libby P., Egan D., and Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96 (1997) 4095-4103
52. Ma L., Hsu C.H., Patterson E., Thadani U., and Robinson C.P. Ricin depresses cardiac function in the rabbit heart. Toxicol Appl Pharmacol 138 (1996) 72-76
53. Christiansen V.J., Hsu C.H., Dormer K.J., and Robinson C.P. The cardiovascular effects of ricin in rabbits. Pharmacol Toxicol 74 (1994) 148-152
54. Christiansen V.J., Hsu C.H., Zhang L., and Robinson C.P. Effects of ricin on the ability of rabbit arteries to contract and relax. J Appl Toxicol 15 (1995) 37-43
55. Li L., Messas E., Batista Jr. E.L., Levine R.A., and Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105 (2002) 861-867
56. Alber D.G., Powell K.L., Vallance P., Goodwin D.A., and Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102 (2000) 779-785
57. Inglesby T.V., Dennis D.T., Henderson D.A., et al., Working Group on CivilianBiodefense. Plague as a biological weapon: medical and public health management. JAMA 283 (2000) 2281-2290
58. Pearson T.A., Bazzarre T.L., Daniels S.R., et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 107 (2003) 645-651
59. Smith Jr. S.C., Allen J., Blair S.N., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
60. Pearson T.A., Blair S.N., Daniels S.R., et al., American Heart Association Science Advisory and Coordinating Committee. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. Circulation 106 (2002) 388-391
61. Hallstrom A.P., Ornato J.P., Weisfeldt M., et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 351 (2004) 637-646